cache/735faaebebaf4346582a76b1ba7d3e2f07f7499a5cbba62d37c43c9a1f5f0e89

COM:SANTEN

Santen Pharmaceutical Co., Ltd

  • Stock

Last Close

1,664.00

22/11 06:45

Market Cap

650.87B

Beta: -

Volume Today

1.48M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
148.66B
-
161.83B
8.86%
195.29B
20.68%
199.10B
1.95%
224.94B
12.98%
234.03B
4.04%
234.03B
0%
249.60B
6.66%
266.26B
6.67%
266.26B
0%
301.96B
13.41%
cost of revenue
58.10B
-
56.37B
2.98%
72.83B
29.19%
74.97B
2.93%
86.38B
15.22%
90.76B
5.08%
90.76B
0%
98.22B
8.22%
109.67B
11.66%
109.67B
0%
138.09B
25.91%
gross profit
90.56B
-
105.46B
16.45%
122.46B
16.12%
124.13B
1.36%
138.56B
11.63%
143.26B
3.39%
143.26B
0%
151.38B
5.67%
156.59B
3.44%
156.59B
0%
163.88B
4.66%
selling and marketing expenses
-4.26B
-
general and administrative expenses
48.89B
-
59.41B
21.50%
62.19B
4.69%
68.79B
10.60%
71.27B
3.61%
71.27B
0%
79.55B
11.62%
84.50B
6.22%
84.50B
0%
91.53B
8.32%
selling general and administrative expenses
48.89B
-
59.41B
21.50%
62.19B
4.69%
68.79B
10.60%
71.27B
3.61%
71.27B
0%
79.55B
11.62%
84.50B
6.22%
84.50B
0%
87.27B
3.28%
research and development expenses
17.48B
-
19.99B
14.38%
22.79B
13.99%
24.40B
7.07%
23.76B
2.62%
23.76B
0%
24.11B
1.49%
26.38B
9.39%
26.38B
0%
24.70B
6.35%
other expenses
154M
-
3.71B
2,311.69%
-37.11B
1,099.27%
6.67B
117.98%
6.69B
0.22%
3.13B
53.16%
3.13B
0%
34.80B
1,011.17%
9.82B
71.77%
9.82B
0%
cost and expenses
121.25B
-
126.46B
4.30%
115.11B
8.97%
166.62B
44.74%
186.25B
11.78%
188.93B
1.44%
188.93B
0%
236.69B
25.28%
230.37B
2.67%
230.37B
0%
250.06B
8.55%
operating expenses
63.14B
-
70.08B
10.99%
42.28B
39.67%
91.65B
116.76%
99.87B
8.97%
98.16B
1.71%
98.16B
0%
138.47B
41.06%
120.70B
12.83%
120.70B
0%
111.97B
7.23%
interest expense
5M
-
279M
5,480%
1.49B
434.77%
1.56B
4.89%
434M
72.27%
2.88B
563.82%
2.88B
0%
1.49B
48.35%
1.21B
18.75%
1.21B
0%
2.66B
120.35%
ebitda
32.02B
-
43.10B
34.61%
90.30B
109.51%
43.27B
52.08%
50.59B
16.92%
56.97B
12.60%
56.97B
0%
30.67B
46.15%
53.88B
75.65%
53.88B
0%
70.08B
30.07%
operating income
27.41B
-
35.37B
29.04%
80.18B
126.66%
32.48B
59.49%
38.69B
19.13%
45.10B
16.56%
45.10B
0%
12.92B
71.36%
35.89B
177.82%
35.89B
0%
51.90B
44.63%
depreciation and amortization
3.93B
-
6.96B
77.23%
9.34B
34.21%
9.88B
5.83%
10.90B
10.26%
10.97B
0.67%
10.97B
0%
16.77B
52.87%
17.05B
1.71%
17.99B
5.51%
167.90K
100.00%
total other income expenses net
-521M
-
489M
193.86%
-710M
245.19%
-657M
7.46%
570M
186.76%
1.73B
202.98%
-1.98B
214.71%
-41.09B
1,974.20%
-259M
99.37%
-270M
4.25%
-14.45B
5,253.33%
income before tax
26.89B
-
35.86B
33.35%
79.47B
121.59%
31.82B
59.96%
39.26B
23.38%
43.12B
9.82%
43.12B
0%
12.42B
71.20%
35.62B
186.81%
35.62B
0%
37.45B
5.15%
income tax expense
9.78B
-
11.83B
20.93%
26.10B
120.58%
8.77B
66.40%
4B
54.38%
11.17B
179.35%
11.17B
0%
5.77B
48.34%
8.43B
45.97%
8.43B
0%
3.17B
62.37%
net income
17.11B
-
24.03B
40.46%
53.37B
122.09%
23.05B
56.81%
35.26B
52.95%
31.94B
9.41%
31.94B
0%
6.83B
78.62%
27.22B
298.51%
27.22B
0%
26.64B
2.12%
weighted average shs out
412.69M
-
413.06M
0.09%
413.79M
0.18%
410.34M
0.83%
406.42M
0.96%
406.17M
0.06%
406.17M
0%
399.46M
1.65%
399.77M
0.08%
399.77M
0%
366.89M
8.23%
weighted average shs out dil
413.95M
-
414.86M
0.22%
415.65M
0.19%
411.88M
0.91%
407.87M
0.97%
407.40M
0.12%
407.40M
0%
400.39M
1.72%
400.44M
0.01%
400.46M
0.00%
368.14M
8.07%
eps
47.78
-
58.18
21.77%
128.99
121.71%
52.96
58.94%
86.76
63.82%
78.64
9.36%
78.64
0%
17.10
78.26%
68.07
298.07%
68.08
0.01%
72.59
6.62%
epsdiluted
47.63
-
57.93
21.63%
128.41
121.66%
52.76
58.91%
86.45
63.86%
78.41
9.30%
78.41
0%
17.06
78.24%
67.97
298.42%
67.97
0%
72.37
6.47%

All numbers in (except ratios and percentages)